Floatz logo

Therapeutic Asset Ratings

13,157 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pembrolizumab
Synovial Sarcoma
Valo Therapeutics OyP2B (63)
Plerixafor
Chronic Myeloid Leukemia
Stanford UniversityP2B (63)
Poly-Iclc
Melanoma
Washington University School of MedicineP2B (63)
Pomalidomide
Myelodysplastic Syndrome
National Cancer Institute (NCI)P2B (63)
PREDNISONE TABLETS
Myeloproliferative Neoplasm
The First Affiliated Hospital of Soochow UniversityP2B (63)
PREDNISONE TABLETS
Indolent B-Cell Non-Hodgkin Lymphoma
Fate TherapeuticsP2B (63)
PREDNISONE TABLETS
Myelodysplastic Syndrome
Indiana UniversityP2B (63)
Ptvg-Hp
Prostate Cancer
University of Wisconsin, MadisonP2B (63)
Regorafenib
Colorectal Carcinoma
City of Hope Medical CenterP2B (63)
Retifanlimab
Renal Cell Carcinoma
University of California, San DiegoP2B (63)
Ribociclib
Ovarian Carcinoma
Avenzo Therapeutics, Inc.P2B (63)
ROSOPATAMAB
Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty LimitedP2B (63)
Ruxolitinib
Chronic Myeloid Leukemia
Center for International Blood and Marrow Transplant ResearchP2B (63)
Ruxolitinib
Myeloproliferative Neoplasm
Center for International Blood and Marrow Transplant ResearchP2B (63)
Sargramostim
Lung Cancer
University of WashingtonP2B (63)
Selinexor
Pancreatic Ductal Adenocarcinoma
University Health Network, TorontoP2B (63)
Sirolimus
Hematopoietic And Lymphoid System Neoplasm
Stanford UniversityP2B (63)
Sirolimus
Disease Related To Hematopoietic Stem Cell Transplant
National Cancer Institute (NCI)P2B (63)
SOMATROPIN RECOMBINANT
Metabolic Dysfunction-Associated Steatotic Liver Disease
Columbia UniversityP2B (63)
TACROLIMUS
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2B (63)
TACROLIMUS
Hematopoietic And Lymphoid System Neoplasm
National Cancer Institute (NCI)P2B (63)
TACROLIMUS
Lymphoblastic Lymphoma
St. Petersburg State Pavlov Medical UniversityP2B (63)
Thiotepa
Primary Central Nervous System Lymphoma
Zhejiang Cancer HospitalP2B (63)
Toripalimab
Cancer
Nanjing Immunophage Biotech Co., LtdP2B (63)
Trastuzumab Emtansine
Her2-Receptor Negative Breast Cancer
University of ChicagoP2B (63)
Showing 1076 to 1100 of 13,157 assets
PreviousPage 44 of 527Next